BioLife Solutions BLFS
$0.00 +$0.00 (0.00%)
Market closed · Oct 22, 12:40 am ET
Open$0.00
Prev close$0.00
Day range$0.00 – $0.00
Volume0.00
Market cap$1.89B
P/E (TTM)32.7
Dividend yield–
BLFS Stock News
Headlines matching BioLife Solutions or the BLFS ticker, most recent first.
- Craig-Hallum Maintains BioLife Solutions(BLFS.US) With Hold Rating
- BioLife Solutions: BioLife Solutions, Inc. - Anticipated Adjustment Option Symbol: BLFS New Symbol: RGEN1
- Earnings Flash (BLFS) BioLife Solutions, Inc. Reports Q2 Revenue $28.5M, Vs. FactSet Est of $27.8M
- Benchmark Co. Downgrades BioLife Solutions(BLFS.US) to Hold Rating Negative
- Stephens Downgrades BioLife Solutions(BLFS.US) to Hold Rating, Raises Target Price to $31 Mixed
- Maxim Group Maintains BioLife Solutions(BLFS.US) With Hold Rating
- A Quick Look at Today's Ratings for BioLife Solutions(BLFS.US), With a Forecast Between $31 to $31
- Craig-Hallum Maintains BioLife Solutions(BLFS.US) With Buy Rating
- Analysts Offer Insights on Healthcare Companies: Tenax Therapeutics (TENX), Biohaven Ltd. (BHVN) and BioLife Solutions (BLFS)
- H.C. Wainwright Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $32
- TD Cowen Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $33
- Lake Street Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $33
- Craig-Hallum Maintains BioLife Solutions(BLFS.US) With Buy Rating, Announces Target Price $32
- Analysts' Top Healthcare Picks: Alto Neuroscience, Inc. (ANRO), BioLife Solutions (BLFS)
- Maxim Group Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $34
No comments yet — be the first to weigh in on BLFS.
Sign in to join the discussion.